Desalkylgidazepam

Desalkylgidazepam is a derivative of gidazepam. It is an analytical standard used to identify a type of benzodiazepine metabolite. Gidazepam, also known as hidazepam or hydazepam, is an atypical form of the drug known as a benzodiazepine derivative. It can be used for treating giddiness. Desalkylgidazepam (other name: bromonordiazepam) is a benzodiazepine substance, a metabolite of gidazepam, with similar effects.

History
This substance is relatively new and became widely used as a research substance in 2022.

Chemistry
Desalkylgidazepam is a metabolite of gidazepam and has a related structure.

Pharmacology
Desalkylgidazepam is a designer substance and its toxicological and pharmacological properties have not been fully studied, all the information presented is based on observation during the study and testing of the substance on mice.
This substance actively affects GABA receptors, which is the reason for its strong sedative effect. it causes such effects as sedation, lowering of blood pressure, sleeping effect.

Legal status
it is a relatively new substance and its legal status is not completely clear. This drug is intended for testing and research for scientific purposes in special laboratories in compliance with all standards and safety measures.

Technical Information:

Product Name: Desalkylgidazepam
Other Name(s): Bromonordiazepam
IUPAC Name: 7-bromo-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
CAS: 2894-61-3
Molar Mass: 315.2 g/mol
Molecular Formula: C15H11BrN2O
InChi Code: InChI=1S/C15H11BrN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)
InChIKey: ATCCWKYKHCKDGT-UHFFFAOYSA-N
Canonical SMILES: O=C1NC2=CC=C(C=C2C(C3=CC=CC=C3)=NC1)Br
Formulation: A solid
NMR Desalkylgidazepam